Transatlantic Taskforce on Antimicrobial Resistance (TATFAR)

TATFAR was created in 2009 to address the urgent threat of antibiotic resistance. TATFAR’s technical experts from Canada, the European Union (EU), Norway, and the United States (U.S.) collaborate and share best practices to strengthen domestic and global efforts.

CDC currently serves as the secretariat for TATFAR, providing administrative support and maintaining the website for the Taskforce.

Key Areas Focus To Reduce the Threat of AR
  1. Improve appropriate therapeutic use of antimicrobial drugs in medical and veterinary communities.
  2. Prevent healthcare and community-associated drug-resistant infections.
  3. Develop strategies for improving the pipeline of new antimicrobial drugs.
Update on Work Plan

TATFAR is developing a new workplan for the next five years. Updating the plan allows members to evaluate current work, assess priorities, engage new partners, and consider new areas for collaboration. The new work plan, along with a TATFAR 2016-2020 progress report, will be available in late 2021.

Contact the CDC TATFAR Liaison

Antibiotic Resistance Coordination and Strategy Unit
Centers for Disease Control and Prevention
1600 Clifton Road NE, MS C-12
Phone: 800-CDC-INFO – (800-232-4636)